Ben Ari Y - Search Results

1

A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.

Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carrière N, Colin O, Defebvre L, Deverdal M, Eusebio A, Ferrier V, Giordana C, Houeto JL, Le Dily S, Mongin M, Thiriez C, Tranchant C, Ravel D, Corvol JC, Rascol O, Ben Ari Y. Damier P, et al. Among authors: ben ari y. Mov Disord. 2024 Mar;39(3):618-622. doi: 10.1002/mds.29726. Epub 2024 Jan 30. Mov Disord. 2024. PMID: 38291616 Clinical Trial.

2

Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.

Fuentes J, Parellada M, Georgoula C, Oliveira G, Marret S, Crutel V, Albarran C, Lambert E, Pénélaud PF, Ravel D, Ben Ari Y. Fuentes J, et al. Among authors: ben ari y. Autism Res. 2023 Oct;16(10):2021-2034. doi: 10.1002/aur.3005. Epub 2023 Oct 4. Autism Res. 2023. PMID: 37794745 Clinical Trial.

3

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders.

Cherubini E, Ben-Ari Y. Cherubini E, et al. Among authors: ben ari y. Brain Sci. 2023 Aug 25;13(9):1240. doi: 10.3390/brainsci13091240. Brain Sci. 2023. PMID: 37759841 Free PMC article.

4

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders.

Delpire E, Ben-Ari Y. Delpire E, et al. Among authors: ben ari y. Cells. 2022 Aug 4;11(15):2419. doi: 10.3390/cells11152419. Cells. 2022. PMID: 35954263 Free PMC article.

5

A quantitative cholinergic and catecholaminergic 3D Atlas of the developing mouse brain.

Riffault B, Cloarec R, Rabiei H, Begnis M, Ferrari DC, Ben-Ari Y. Riffault B, et al. Among authors: ben ari y. Neuroimage. 2022 Oct 15;260:119494. doi: 10.1016/j.neuroimage.2022.119494. Epub 2022 Jul 21. Neuroimage. 2022. PMID: 35870696 Free article.

6

Prenatal reduction of E14.5 embryonically fate-mapped pyramidal neurons in a mouse model of autism.

Dufour A, Dumon C, Gouty-Colomer LA, Eftekhari S, Ferrari DC, Ben-Ari Y. Dufour A, et al. Among authors: ben ari y. Eur J Neurosci. 2022 Jul;56(2):3875-3888. doi: 10.1111/ejn.15724. Epub 2022 Jun 9. Eur J Neurosci. 2022. PMID: 35636970

7

[Early prognostic of ASD: A challenge].

Ben-Ari Y, Caly H, Rabiei H, Lemonnier É. Ben-Ari Y, et al. Med Sci (Paris). 2022 May;38(5):431-437. doi: 10.1051/medsci/2022054. Epub 2022 May 24. Med Sci (Paris). 2022. PMID: 35608465 Free article. French.

8

The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis.

Ben-Ari Y, Cherubini E. Ben-Ari Y, et al. Cells. 2022 Jan 24;11(3):396. doi: 10.3390/cells11030396. Cells. 2022. PMID: 35159205 Free PMC article. Review.

9

[Deciphering cortical GABAergic inhibition].

Ben-Ari Y. Ben-Ari Y. Med Sci (Paris). 2021 Nov;37(11):1032-1034. doi: 10.1051/medsci/2021138. Epub 2021 Dec 1. Med Sci (Paris). 2021. PMID: 34851281 Free article. French. No abstract available.

10

Krešimir Krnjević (1927-2021) and GABAergic inhibition: a lifetime dedication.

Ben-Ari Y, Cherubini E, Avoli M. Ben-Ari Y, et al. Can J Physiol Pharmacol. 2022 Jan;100(1):1-4. doi: 10.1139/cjpp-2021-0451. Epub 2021 Nov 12. Can J Physiol Pharmacol. 2022. PMID: 34767471 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

550 results

Search Page

Filters